Inhibition of CYP19A1 aromatase and suppression of estradiol production by polyhalogenated carbazoles: an in vitro and in silico study
Bioorganic Chemistry · 2026-12 · 185 · 110730
DOI: 10.1016/j.bioorg.2026.110730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-12. Verfasst von Jianmin Sang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Polyhalogenated carbazoles (PHCZs) are emerging contaminants with largely unknown endocrine-disrupting effects. We evaluated 11 PHCZs against human and rat CYP19A1 via enzymatic, cellular, and computational assays. Three compounds (136-BCZ, 1-B-36-CCZ, 36-ICZ) inhibited human CYP19A1 with IC50 of 20.6, 18.1, and 4.7 μM (rat: 32.6, 28.3, 7.5 μM). Kinetic analyses showed mixed inhibition with Ki values of 24.29, 20.4, and 4.0 μM for human CYP19A1, indicating binding to both free enzyme and enzyme-substrate complex. Docking and 200 ns MD simulations revealed stable anchoring in the catalytic pocket via halogen-mediated hydrophobic interactions with Ile305, Val370, Met374, consistent with the strongest inhibitory activity of 36-ICZ due to iodine polarizability. Cellular assays in BeWo cells confirmed concentration-dependent estradiol suppression (5-20 μM) by all three. Network toxicology identified CYP19A1 as a central node linking PHCZs to polycystic ovary syndrome and osteoporosis; bivariate correlation and 3D-QSAR modeling further revealed logP and pKa as key determinants of activity. Collectively, this study provides the first direct mechanistic evidence that PHCZs inhibit CYP19A1, revealing a specific endocrine-disrupting pathway with reproductive health implications and a framework for risk assessment and safer design.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
- Department of Clinical Laboratory, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China. Electronic address: zongming@tongji.edu.cn.
- Department of Clinical Laboratory, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China. Electronic address: fanlieying@tongji.edu.cn.
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Zitieren
APA
Sang, J., Yang, Z., Ding, X., Gao, R., Lei, C., He, L., Lu, L., Yu, S., Zong, M., & Fan, L. (2026). Inhibition of CYP19A1 aromatase and suppression of estradiol production by polyhalogenated carbazoles: an in vitro and in silico study. Bioorganic Chemistry, 185, 110730. https://doi.org/10.1016/j.bioorg.2026.110730
Vancouver
Sang J, Yang Z, Ding X, Gao R, Lei C, He L, et al. Inhibition of CYP19A1 aromatase and suppression of estradiol production by polyhalogenated carbazoles: an in vitro and in silico study. Bioorganic Chemistry. 2026;185:110730. doi:10.1016/j.bioorg.2026.110730
BibTeX
@article{Sang2026,
author = {Sang, Jianmin and Yang, Zicheng and Ding, Xuewei and Gao, Ruizi and Lei, Chengtao and He, Long and Lu, Liu and Yu, Shanshan and Zong, Ming and Fan, Lieying},
title = {Inhibition of CYP19A1 aromatase and suppression of estradiol production by polyhalogenated carbazoles: an in vitro and in silico study},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {185},
pages = {110730},
doi = {10.1016/j.bioorg.2026.110730}
}
EUVIMED